Loading...
XASX
BGT
Market cap2mUSD
Oct 09, Last price  
0.01AUD
1D
0.00%
1Q
-17.65%
IPO
-93.64%
Name

Bio-Gene Technology Ltd

Chart & performance

D1W1MN
XASX:BGT chart
P/E
—
P/S
—
EPS
—
Div yield, %
—
Shrs. gr., 5y
17.63%
Rev. gr., 5y
-48.56%
Revenues
0
760186,4156,316344,450508,758907,58062,610445,726149,23218,32000
Net income
-2m
L-9.81%
-87,306-98,261-322,518-1,054,902-2,833,050-1,919,723-1,933,099-2,396,264-2,914,193-3,095,782-2,409,179-2,584,468-2,330,805
CFO
-2m
L-23.76%
-47,567-126,950-419,345-729,152-2,373,454-2,201,479-1,644,691-1,825,52243,515-3,276,354-2,754,245-2,542,768-1,938,705

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Bio-Gene Technology Limited, an agricultural technology firm based in Australia, focuses on the development and commercialization of insecticides and pesticides. These solutions are designed for a range of uses, encompassing animal health, crop protection, public health, and consumer applications. The company's key products include Flavocide, an insecticide utilizing beta-triketone technology, and Qcide, a natural oil derived from a specific cultivar of eucalyptus cloeziana. Bio-Gene maintains a research partnership with James Cook University to develop a tissue culture system, a critical step for expanding tree plantations and increasing future Qcide oil production. Furthermore, the company collaborates with BASF, the Grains Research and Development Corporation, and the Queensland Department of Agriculture and Fisheries to assess its products' effectiveness against grain storage pests. Established in 1995, Bio-Gene Technology Limited operates from its headquarters in Melbourne, Australia.

Key people

Soo Ding Huong
Non-Executive Chairman of the Board · since 2023
Drew Speedy
Chief Financial Officer, Company Secretary · since 2026
Tim Grogan
Chief Executive Officer, Managing Director · since 2023
Peter May
Executive Director - Research and Development · since 2018
Owen Grogan
Director · since 2023
Non-Executive Director · since 2021
Christopher Ramsay
Non-Executive Director · since 2023
IPO date
Nov 29, 2017
Employees
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑062025‑062024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑06
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT